Abstract
Current available biomarkers cannot identify myocardial ischemia without necrosis. To overcome this issue and to increase diagnostic power, we evaluated the activation of the three MAPK pathways, ERK1/2, JNK and p38, in T lymphocytes of patients with acute coronary syndromes (ACS). We included sixty consecutive patients affected by either unstable angina (UA, N = 22), Non- ST-segment elevation MI (NSTEMI, N = 19) or ST-segment elevation MI (STEMI, N = 19). Two separate groups of patients were matched as controls: healthy subjects (CTRL, N = 20) and patients with stable coronary artery disease (CAD, N = 21). MAPK activation in T lymphocytes, measured by phospho-ERK1/2, phospho-JNK and phospho-p38 levels, was assessed by flow cytometry analysis which revealed significantly increased phosphorylated levels of ERK1/2 in patients with UA, compared to controls. In UA patients no significant changes were detected for phospho-JNK compared to both control groups. NSTEMI and STEMI groups showed a statistically significant increase in both phospho-ERK1/2 and phospho-JNK, compared to control groups. All ACS groups demonstrated significantly increased phosphorylation of p38 compared to CTRL, but not CAD. ROC curves showed that a cut-off value of 22.5 intensity of fluorescence for phospho-ERK1/2 was able to significantly discriminate UA patients from patients with stable angina with 78% sensitivity and 90% specificity. Therefore, a differential MAPK activation in T lymphocytes denotes patients with ACS. Indeed, patients with unstable angina are identified with high specificity by activated ERK1/2 and normal JNK levels. These data could represent a valuable new molecular signature to be used as specific biomarkers for the diagnosis of unstable angina within ACS.
Similar content being viewed by others
References
Antman EM, Sacks DB, Rifai N, McCabe CH, Cannon CP, Braunwald E (1998) Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. J Am Coll Cardiol 31:326–330. doi:10.1016/S0735-1097(97)00485-3
Berk BC, Weintraub WS, Alexander RW (1990) Elevation of C-reactive protein in “active” coronary artery disease. Am J Cardiol 65:168–172. doi:10.1016/0002-9149(90)90079-G
Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94:874–877
Biasucci LM, D’Onofrio G, Liuzzo G, Zini G, Monaco C, Caligiuri G, Tommasi M, Rebuzzi AG, Maseri A (1996) Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 27:611–616. doi:10.1016/0735-1097(95)00524-2
Bonaca MP, Morrow DA (2008) Defining a role for novel biomarkers in acute coronary syndromes. Clin Chem 54:1424–1431. doi:10.1373/clinchem.2008.105387
Böse D, von Birgelen C, Zhou XY, Schmermund A, Philipp S, Sack S, Konorza T, Möhlenkamp S, Leineweber K, Kleinbongard P, Wijns W, Heusch G, Erbel R (2008) Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol 103:587–597. doi:10.1007/s00395-008-0745-9
Böse D, Leineweber K, Konorza T, Zahn A, Bröcker-Preuss M, Mann K, Haude M, Erbel R, Heusch G (2007) Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am J Physiol Heart Circ Physiol 292:H2295–H2299. doi:10.1152/ajpheart.01116.2006
Buja LM, Willerson JT (1994) Role of inflammation in coronary plaque disruption. Circulation 89:503–505
Caligiuri G, Liuzzo G, Biasucci LM, Maseri A (1998) Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 32:1295–1304. doi:10.1016/S0735-1097(98)00410-0
Cook SA, Sugden PH, Clerk A (1999) Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 31:1429–1434. doi:10.1006/jmcc.1999.0979
Dernbach E, Randriamboavonjy V, Fleming I, Zeiher AM, Dimmeler S, Urbich C (2008) Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors. Basic Res Cardiol 103:572–581. doi:10.1007/s00395-008-0734-z
Esposito G, Perrino C, Schiattarella GG, Belardo L, di Pietro E, Franzone A, Capretti G, Gargiulo G, Pironti G, Cannavo A, Sannino A, Izzo R, Chiariello M (2010) Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. Hypertension 55:137–143. doi:10.1161/HYPERTENSIONAHA.109.135467
Friedrich EB, Werner C, Walenta K, Böhm M, Scheller B (2009) Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease. Basic Res Cardiol 104:613–620. doi:10.1007/s00395-009-0022-6
Gasparri C, Curcio A, Torella D, Gaspari M, Celi V, Salituri F, Boncompagni D, Torella M, Gulletta E, Cuda G, Indolfi C (2010) Proteomics reveals high levels of vitamin D binding protein in myocardial infarction. Front Biosci 2:796–804. doi:10.2741/E140
Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, Jaffe AS, Jesse RL, Newby LK, Ohman EM, Peterson ED, Pollack CV (2005) American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care); Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group; Society of Chest Pain Centers. Interdisciplinary Working Group, in Collaboration With the Society of Chest on Cardiovascular Nursing, and Quality of Care and Outcomes Research Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council Department: A Scientific Statement From the American Heart Association Angina/Non–ST-Segment Elevation Myocardial Infarction in the Emergency. Circulation 111:2699–2710. doi:10.1161/01.CIR.0000165556.44271.BE
Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, Tanaka M, Ueda A, Kominami G, Kambara H, Kimura T, Kita T (2005) Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome a novel marker for early diagnosis. Circulation 112:812–818. doi:10.1161/CIRCULATIONAHA.104.468397
Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, Erbel R (2009) Coronary microembolization: from bedside to bench and back to bedside. Circulation 120:1822–1836. doi:10.1161/CIRCULATIONAHA.109.888784
Heusch P, Canton M, Aker S, van de Sand A, Konietzka I, Rassaf T, Menazza S, Brodde OE, Di Lisa F, Heusch G, Schulz R (2010) The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits. Br J Pharmacol 160:1408–1416. doi:10.1111/j.1476-5381.2010.00793.x
Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G, Chiariello M (1995) Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med 6:541–545. doi:10.1038/nm0695-541
Indolfi C, Chiariello M, Avvedimento EV (1996) Selective gene therapy for proliferative disorders: sense and antisense. Nat Med 2:634–635. doi:10.1038/nm0696-634
Indolfi C, Avvedimento EV, Di Lorenzo E, Esposito G, Rapacciuolo A, Giuliano P, Grieco D, Cavuto L, Stingone AM, Ciullo I, Condorelli G, Chiariello M (1997) Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med 7:775–779. doi:10.1038/nm0797-775
Indolfi C, Curcio A, Chiariello M (2003) Simvastatin reduces neointimal thickening after experimental angioplasty. Circulation 107:e25. doi:10.1161/01.CIR.0000050549.85811.9D
Jacquet S, Nishino Y, Kumphune S, Sicard P, Clark JE, Kobayashi KS, Flavell RA, Eickhoff J, Cotten M, Marber MS (2008) The role of RIP2 in p38 MAPK activation in the stressed heart. J Biol Chem 283:11964–11971. doi:10.1074/jbc.M707750200
Konstandin MH, Aksoy H, Wabnitz GH, Volz C, Erbel C, Kirchgessner H, Giannitsis E, Katus HA, Samstag Y, Dengler TJ (2009) Beta2-integrin activation on T cell subsets is an independent prognostic factor in unstable angina pectoris. Basic Res Cardiol 104:341–351. doi:10.1007/s00395-008-0770-8
Kovanen PT, Kaartinen M, Paavonen T (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084–1088
Libby P (2001) Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365–372
Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417–424. doi:10.1056/NEJM199408183310701
Liuzzo G, Biasucci LM, Trotta G, Brugaletta S, Pinnelli M, Digianuario G, Rizzello V, Rebuzzi AG, Rumi C, Maseri A, Crea F (2007) Unusual CD4 + CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 50:1450–1458. doi:10.1016/j.jacc.2007.06.040
Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F, Specchia G (1993) Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88:358–363
Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER (2005) Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol 45:1939–1945. doi:10.1016/j.jacc.2005.03.040
Michel MC, Li Y, Heusch G (2001) Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol 363:245–266. doi:10.1007/s002100000363
Morrow DA, Braunwald E (2003) Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 108:250–252. doi:10.1161/01.CIR.0000078080.37974.D2
Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AH, Christenson RH, Apple FS, Francis G, Tang W (2007) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53:552–574. doi:10.1373/clinchem.2006.084194
Mulvihill N, Foley B, Ghaisas N, Murphy R, Crean P, Walsh M (2000) Evidence of prolonged inflammation in unstable angina and non Q-wave myocardial infarction. J Am Coll Cardiol 34:1210–1216. doi:10.1016/S0735-1097(00)00824-X
Neri Serneri GG, Prisco D, Martini F, Gori AM, Brunelli T, Poggesi L, Rostagno C, Gensini GF, Abbate R (1997) Acute T-cell activation is detectable in unstable angina. Circulation 95:1806–1812
Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O’Hanesian MA, Wagner GS, Kleiman NS, Harrell FE Jr, Califf RM, Topol EJ (1996) Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 335:1333–1341. doi:10.1056/NEJM199610313351801
Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, Ali N, Obermueller SD, Triana FJ, Zimmerman JL, Perryman MB, Roberts R (1994) Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331:561–566. doi:10.1056/NEJM199409013310901
Quilici J, Banzet N, Paule P, Meynard JB, Mutin M, Bonnet JL, Ambrosi P, Sampol J, Dignat-George F (2004) Circulating endothelial cell count as a diagnostic marker for non–st-elevation acute coronary syndromes. Circulation 110:1586–1591. doi:10.1161/01.CIR.0000142295.85740.98
Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes simultaneous assessment of Troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105:1760–1763. doi:10.1161/01.CIR.0000015464.18023.0A
Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G (2003) Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 10:1355–1357. doi:10.1096/fj.02-0975fje
Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, Heusch G (2002) p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55:690–700. doi:10.1016/S0008-6363(02)00319-X
Seeger FH, Sedding D, Langheinrich AC, Haendeler J, Zeiher AM, Dimmeler S (2010) Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression. Basic Res Cardiol 105:389–397. doi:10.1007/s00395-009-0072-9
Sun C, Liang C, Ren Y, Zhen Y, He Z, Wang H, Tan H, Pan X, Wu Z (2009) Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res Cardiol 104:42–49. doi:10.1007/s00395-008-0738-8
Tamer L, Ercan B, Camsari A, Yildirim H, Ciçek D, Sucu N, Ateş NA, Atik U (2004) Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol 99:223–229. doi:10.1007/s00395-004-0465-8
Walcher D, Vasic D, Heinz P, Bach H, Durst R, Hausauer A, Hombach V, Marx N (2010) LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration. Basic Res Cardiol 105:487–494. doi:10.1007/s00395-010-0092-5
Wang Y (2007) Mitogen-activated protein kinases in heart development and diseases. Circulation 116:1413–1423. doi:10.1161/CIRCULATIONAHA.106.679589
Acknowledgments
This study was supported, in part, by Grants for Scientific Research from the Ministry of the Education, University and Research of Italy (PRIN2003065977_002, RBAU018WWP_001), by Ricerca sanitaria finalizzata 2007—Programma Strategico APICE “Activity of Platelets after Inhibition and Cardiovascular Events”, and by GENECOR, a non-profit organization.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Indolfi, C., Gasparri, C., Vicinanza, C. et al. Mitogen-activated protein kinases activation in T lymphocytes of patients with acute coronary syndromes. Basic Res Cardiol 106, 667–679 (2011). https://doi.org/10.1007/s00395-011-0172-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00395-011-0172-1